PubMed:10050877
Annnotations
jnlpba-st-training
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 11-16 | protein | denotes | c-Rel |
| T2 | 20-42 | DNA | denotes | STAT5 target sequences |
| T3 | 46-72 | cell_type | denotes | HTLV-I-transformed T cells |
| T4 | 179-186 | cell_type | denotes | T cells |
| T5 | 309-335 | cell_type | denotes | HTLV-I-transformed T cells |
| T6 | 378-398 | protein | denotes | NF-kappaB/Rel family |
| T7 | 479-496 | cell_type | denotes | transformed cells |
| T8 | 507-528 | protein | denotes | NF-kappaB/Rel factors |
| T9 | 567-606 | protein | denotes | T-cell growth factor interleukin (IL)-2 |
| T10 | 650-654 | protein | denotes | IL-2 |
| T11 | 677-701 | cell_line | denotes | HTLV-I-transformed cells |
| T12 | 739-760 | protein | denotes | NF-kappaB/Rel members |
| T13 | 776-781 | protein | denotes | c-Rel |
| T14 | 820-825 | protein | denotes | STAT5 |
| T15 | 864-868 | protein | denotes | IL-2 |
| T16 | 947-952 | protein | denotes | c-Rel |
| T17 | 960-965 | protein | denotes | STAT5 |
| T18 | 986-1001 | DNA | denotes | Fc gammaR1 gene |
| T19 | 1063-1068 | protein | denotes | c-Rel |
| T20 | 1076-1096 | DNA | denotes | Fc gammaR1 STAT site |
| T21 | 1118-1142 | cell_type | denotes | peripheral blood T cells |
| T22 | 1290-1303 | protein | denotes | NF-kappaB/Rel |
| T23 | 1345-1371 | cell_line | denotes | HTLV-I-transformed T cells |
| T24 | 1407-1413 | DNA | denotes | kappaB |
| T25 | 1426-1440 | DNA | denotes | STAT enhancers |
genia-medco-coref
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| C1 | 11-16 | NP | denotes | c-Rel |
| C2 | 46-72 | NP | denotes | HTLV-I-transformed T cells |
| C3 | 150-186 | NP | denotes | subsequent transformation of T cells |
| C4 | 188-193 | NP | denotes | which |
| C5 | 309-335 | NP | denotes | HTLV-I-transformed T cells |
| C6 | 378-423 | NP | denotes | NF-kappaB/Rel family of transcription factors |
| C7 | 425-430 | NP | denotes | which |
| C8 | 473-496 | NP | denotes | these transformed cells |
| C9 | 507-528 | NP | denotes | NF-kappaB/Rel factors |
| C10 | 626-630 | NP | denotes | they |
| C11 | 677-701 | NP | denotes | HTLV-I-transformed cells |
| C12 | 776-781 | NP | denotes | c-Rel |
| C13 | 820-825 | NP | denotes | STAT5 |
| C14 | 827-897 | NP | denotes | a key transcription factor mediating IL-2-induced T-cell proliferation |
| C15 | 947-952 | NP | denotes | c-Rel |
| C16 | 1063-1068 | NP | denotes | c-Rel |
| C17 | 1112-1142 | NP | denotes | human peripheral blood T cells |
| C18 | 1236-1247 | NP | denotes | these cells |
| C19 | 1269-1284 | NP | denotes | the possibility |
| C20 | 1285-1289 | NP | denotes | that |
| C21 | 1290-1303 | NP | denotes | NF-kappaB/Rel |
| C22 | 1345-1371 | NP | denotes | HTLV-I-transformed T cells |
| R1 | C4 | C3 | coref-relat | which,subsequent transformation of T cells |
| R2 | C5 | C2 | coref-ident | HTLV-I-transformed T cells,HTLV-I-transformed T cells |
| R3 | C7 | C6 | coref-relat | which,NF-kappaB/Rel family of transcription factors |
| R4 | C8 | C5 | coref-ident | these transformed cells,HTLV-I-transformed T cells |
| R5 | C9 | C6 | coref-ident | NF-kappaB/Rel factors,NF-kappaB/Rel family of transcription factors |
| R6 | C10 | C9 | coref-pron | they,NF-kappaB/Rel factors |
| R7 | C11 | C8 | coref-ident | HTLV-I-transformed cells,these transformed cells |
| R8 | C12 | C1 | coref-ident | c-Rel,c-Rel |
| R9 | C14 | C13 | coref-appos | a key transcription factor mediating IL-2-induced T-cell proliferation,STAT5 |
| R10 | C15 | C12 | coref-ident | c-Rel,c-Rel |
| R11 | C16 | C15 | coref-ident | c-Rel,c-Rel |
| R12 | C18 | C17 | coref-ident | these cells,human peripheral blood T cells |
| R13 | C20 | C19 | coref-relat | that,the possibility |
| R14 | C21 | C9 | coref-ident | NF-kappaB/Rel,NF-kappaB/Rel factors |
| R15 | C22 | C11 | coref-ident | HTLV-I-transformed T cells,HTLV-I-transformed cells |
pubmed-sentences-benchmark
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| S1 | 0-73 | Sentence | denotes | Binding of c-Rel to STAT5 target sequences in HTLV-I-transformed T cells. |
| S2 | 74-288 | Sentence | denotes | The type I human T-cell leukemia virus (HTLV-I) induces abnormal growth and subsequent transformation of T cells, which is associated with the development of an acute T-cell malignancy termed adult T-cell leukemia. |
| S3 | 289-497 | Sentence | denotes | A characteristic of HTLV-I-transformed T cells is the constitutive nuclear expression of NF-kappaB/Rel family of transcription factors, which appears to be essential for the growth of these transformed cells. |
| S4 | 498-702 | Sentence | denotes | Although NF-kappaB/Rel factors are known to induce the expression of T-cell growth factor interleukin (IL)-2, it is unclear how they participate in the IL-2-independent growth of HTLV-I-transformed cells. |
| S5 | 703-898 | Sentence | denotes | In this study, we show that certain NF-kappaB/Rel members, predominantly c-Rel, interact with enhancer sequences for STAT5, a key transcription factor mediating IL-2-induced T-cell proliferation. |
| S6 | 899-1051 | Sentence | denotes | Reporter gene assays reveal that the binding of c-Rel to the STAT5 site present in the Fc gammaR1 gene leads to potent transactivation of this enhancer. |
| S7 | 1052-1248 | Sentence | denotes | Binding of c-Rel to the Fc gammaR1 STAT site also occurs in human peripheral blood T cells immortalized with HTLV-I in vitro and is correlated with enhanced levels of proliferation of these cells. |
| S8 | 1249-1441 | Sentence | denotes | These results raise the possibility that NF-kappaB/Rel may participate in the growth control of HTLV-I-transformed T cells by regulating genes driven by both kappaB and certain STAT enhancers. |
GENIAcorpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 11-16 | protein_molecule | denotes | c-Rel |
| T2 | 20-42 | DNA_domain_or_region | denotes | STAT5 target sequences |
| T3 | 46-72 | cell_type | denotes | HTLV-I-transformed T cells |
| T4 | 78-112 | virus | denotes | type I human T-cell leukemia virus |
| T5 | 114-120 | virus | denotes | HTLV-I |
| T6 | 179-186 | cell_type | denotes | T cells |
| T7 | 235-258 | other_name | denotes | acute T-cell malignancy |
| T8 | 266-287 | other_name | denotes | adult T-cell leukemia |
| T9 | 309-315 | virus | denotes | HTLV-I |
| T10 | 378-398 | protein_family_or_group | denotes | NF-kappaB/Rel family |
| T11 | 479-496 | cell_type | denotes | transformed cells |
| T12 | 507-528 | protein_family_or_group | denotes | NF-kappaB/Rel factors |
| T13 | 567-606 | protein_molecule | denotes | T-cell growth factor interleukin (IL)-2 |
| T14 | 650-654 | protein_molecule | denotes | IL-2 |
| T15 | 677-683 | virus | denotes | HTLV-I |
| T16 | 683-701 | cell_type | denotes | -transformed cells |
| T17 | 739-760 | protein_family_or_group | denotes | NF-kappaB/Rel members |
| T18 | 776-781 | protein_molecule | denotes | c-Rel |
| T19 | 820-825 | protein_molecule | denotes | STAT5 |
| T20 | 864-868 | protein_molecule | denotes | IL-2 |
| T21 | 947-952 | protein_molecule | denotes | c-Rel |
| T22 | 960-965 | protein_molecule | denotes | STAT5 |
| T23 | 986-1001 | DNA_domain_or_region | denotes | Fc gammaR1 gene |
| T24 | 1063-1068 | protein_molecule | denotes | c-Rel |
| T25 | 1076-1096 | DNA_domain_or_region | denotes | Fc gammaR1 STAT site |
| T26 | 1118-1142 | cell_type | denotes | peripheral blood T cells |
| T27 | 1161-1167 | virus | denotes | HTLV-I |
| T28 | 1290-1303 | protein_family_or_group | denotes | NF-kappaB/Rel |
| T29 | 1345-1351 | virus | denotes | HTLV-I |
| T30 | 1407-1413 | DNA_domain_or_region | denotes | kappaB |
| T31 | 1426-1440 | DNA_domain_or_region | denotes | STAT enhancers |
PubmedHPO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 98-106 | HP_0001909 | denotes | leukemia |
| T2 | 130-145 | HP_0001507 | denotes | abnormal growth |
| T3 | 279-287 | HP_0001909 | denotes | leukemia |